Global Leading Market Research Publisher QYResearch announces the release of its latest report “Synthetic Aluminum Silicate – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032”. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Synthetic Aluminum Silicate market, including market size, share, demand, industry development status, and forecasts for the next few years.
Addressing core industry needs: Pharmaceutical formulations face challenges with poor powder flowability, tablet disintegration, API caking, and suspension uniformity – impacting manufacturing efficiency and drug release consistency. Synthetic aluminum silicate solves this as a multifunctional excipient offering adsorptive, disintegrating, suspending, and stabilizing properties. Key drivers include generic drug manufacturing, formulation complexity, and functional excipient demand.
The global market for Synthetic Aluminum Silicate was estimated to be worth US$ 18.3 million in 2025 and is projected to reach US$ 27.7 million, growing at a CAGR of 6.2% from 2026 to 2032. In 2024, global production reached approximately 2,125 tons, with an average price of about US$ 8,200 per ton.
Synthetic aluminum silicate is an inorganic compound produced by the reaction of silicate and aluminum salts, typically appearing as a fine white powder with excellent adsorptive and suspending properties. In pharmaceutical excipients, it is commonly employed as an adsorbent, disintegrant, suspending agent, and stabilizer. It helps improve powder flowability, prevents caking of active ingredients in tablets or capsules, and enhances dispersion and uniformity in suspensions. Widely used in oral solid and liquid dosage forms, synthetic aluminum silicate is recognized for its safety, compatibility, and functional versatility in pharmaceutical formulations.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)
https://www.qyresearch.com/reports/6098176/synthetic-aluminum-silicate
Market Segmentation & Key Players
The Synthetic Aluminum Silicate market is segmented as below:
Leading Suppliers: Kyowa Chemical Industry, Hunan Jiudian Hongyang Pharmaceutical, MLA Industries, Guangdong Xinyuan Technology Development, Nanjing Healthnice Pharmaceutical.
Segment by Type (Mesh Size): 80 Mesh | 100 Mesh | 200 Mesh
Segment by Application: Tablets | Capsules | Oral Suspensions | Topical Formulations
Exclusive Industry Insights
Discrete chemical synthesis: Synthetic aluminum silicate is produced via controlled reaction of sodium silicate and aluminum sulfate, followed by filtration, drying, and milling. Particle size distribution (mesh size) determines functional properties – finer particles (200 mesh) offer higher surface area for adsorption but lower flowability.
Technical differentiation – mesh size applications:
- 80 Mesh (22% revenue): Coarsest, best flowability. For direct compression tablet formulations requiring high-speed manufacturing.
- 100 Mesh (48% revenue): Standard grade, balance of flow and surface area. Largest segment for tablets and capsules.
- 200 Mesh (30% revenue): Finest, highest adsorption capacity. For oral suspensions, topical formulations. Fastest-growing (CAGR 7.2%).
Recent 6-month data (Oct 2025 – Mar 2026):
- Tablets largest application (48% revenue) – disintegrant, adsorbent for moisture-sensitive APIs.
- Oral suspensions fastest-growing (CAGR 7.5%), driven by pediatric and geriatric liquid formulations.
- Average price increased 5% due to raw material (aluminum sulfate) cost inflation.
User case – Generic tablet manufacturer (India, 10 billion tablets/year): Incorporating synthetic aluminum silicate (100 mesh) at 2–5% in direct compression formulations improved tablet hardness consistency (RSD reduced from 8% to 3%) and reduced disintegration time from 12 to 8 minutes. Annual savings from reduced batch failures: US$ 1.2M.
Application insights: Tablets (48%) – disintegrant for fast release, adsorbent for oily/labile APIs. Capsules (22%) – glidant for powder filling, anti-caking agent. Oral Suspensions (18%) – suspending agent, viscosity modifier. Topical Formulations (12%) – thickening agent, stabilizer for creams/ointments.
Functional properties by application:
| Application | Key Function | Typical Usage |
|---|---|---|
| Tablets | Disintegrant, adsorbent | 2–5% |
| Capsules | Glidant, anti-caking | 1–3% |
| Suspensions | Suspending agent | 0.5–2% |
| Topical | Thickener, stabilizer | 1–5% |
Regional snapshot: Asia-Pacific leads with 62% revenue share (China 45%, India 12%), driven by generic drug manufacturing. North America holds 18%, Europe 15%.
Conclusion
The synthetic aluminum silicate market grows steadily, driven by generic drug manufacturing, formulation complexity, and functional excipient demand. Success depends on particle size control, consistent quality, and multifunctional performance. The projected US$ 27.7 million market by 2032 appears achievable.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
